Jort S.A. van der Geest , Willem B. van Ham , Ernest Diez Benavente , Mohsin El Amrani , M. Mostafa Mokhles , Marish I.F.J. Oerlemans , Pieter A. Doevendans , Teun P. de Boer , Joost P.G. Sluijter , Linda W. van Laake , Vasco Sampaio-Pinto
{"title":"活体心肌切片保留患者特异性特征:洞察病因和治疗史","authors":"Jort S.A. van der Geest , Willem B. van Ham , Ernest Diez Benavente , Mohsin El Amrani , M. Mostafa Mokhles , Marish I.F.J. Oerlemans , Pieter A. Doevendans , Teun P. de Boer , Joost P.G. Sluijter , Linda W. van Laake , Vasco Sampaio-Pinto","doi":"10.1016/j.jhlto.2025.100345","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Living myocardial slices (LMS) are an emerging translational <em>ex vivo</em> model for studying myocardial function, disease mechanisms, and therapeutics. However, the extent to which <em>ex vivo</em> findings correlate with clinical characteristics is unknown. This study aimed to evaluate whether LMS retain patient-specific functional and pathological characteristics, reflecting diverse etiologies, pharmacological regimens, and clinical interventions.</div></div><div><h3>Methods</h3><div>300-µm-thick LMS were prepared from myocardial biopsies of end-stage heart failure patients (<em>N</em> = 12, <em>n</em> = 138). Functional assessment of freshly prepared LMS included refractory period, stimulation threshold, force-frequency relationship, post pause potentiation, contractile force, alongside simultaneous optical recordings of calcium transients and action potentials. Variability and grouping analyses were conducted to identify features linked to patient-specific parameters, such as etiology and therapeutic history, including prior left ventricular assist device (LVAD) implantation and amiodarone usage.</div></div><div><h3>Results</h3><div>LMS exhibited lower intrapatient variability (LMS from the same patient) compared to interpatient variability (LMS from different patients), confirming their ability to retain patient-specific functional properties. LMS from LVAD-treated patients exhibited reduced intrapatient variability and reduced diastolic tension, correlated with lower N-terminal pro-B-type natriuretic peptide levels. Stratification by etiology revealed distinct functional characteristics, including enhanced contractile force in titin-mutant LMS and a positive force-frequency relationship in ischemic cardiomyopathy-derived LMS. LMS derived from amiodarone-treated patients demonstrated prolonged action potential duration, reduced excitability at higher pacing frequencies, and enhanced post pause potentiation, reflecting the drug’s established pharmacological effects.</div></div><div><h3>Conclusions</h3><div>LMS effectively capture distinct functional parameters associated with patient-specific features. These findings establish LMS as a valuable translational platform for personalized cardiac research, therapeutic testing, and precision medicine.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"9 ","pages":"Article 100345"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Living myocardial slices retain patient-specific features: Insights into etiology and therapeutic history\",\"authors\":\"Jort S.A. van der Geest , Willem B. van Ham , Ernest Diez Benavente , Mohsin El Amrani , M. Mostafa Mokhles , Marish I.F.J. Oerlemans , Pieter A. Doevendans , Teun P. de Boer , Joost P.G. Sluijter , Linda W. van Laake , Vasco Sampaio-Pinto\",\"doi\":\"10.1016/j.jhlto.2025.100345\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Living myocardial slices (LMS) are an emerging translational <em>ex vivo</em> model for studying myocardial function, disease mechanisms, and therapeutics. However, the extent to which <em>ex vivo</em> findings correlate with clinical characteristics is unknown. This study aimed to evaluate whether LMS retain patient-specific functional and pathological characteristics, reflecting diverse etiologies, pharmacological regimens, and clinical interventions.</div></div><div><h3>Methods</h3><div>300-µm-thick LMS were prepared from myocardial biopsies of end-stage heart failure patients (<em>N</em> = 12, <em>n</em> = 138). Functional assessment of freshly prepared LMS included refractory period, stimulation threshold, force-frequency relationship, post pause potentiation, contractile force, alongside simultaneous optical recordings of calcium transients and action potentials. Variability and grouping analyses were conducted to identify features linked to patient-specific parameters, such as etiology and therapeutic history, including prior left ventricular assist device (LVAD) implantation and amiodarone usage.</div></div><div><h3>Results</h3><div>LMS exhibited lower intrapatient variability (LMS from the same patient) compared to interpatient variability (LMS from different patients), confirming their ability to retain patient-specific functional properties. LMS from LVAD-treated patients exhibited reduced intrapatient variability and reduced diastolic tension, correlated with lower N-terminal pro-B-type natriuretic peptide levels. Stratification by etiology revealed distinct functional characteristics, including enhanced contractile force in titin-mutant LMS and a positive force-frequency relationship in ischemic cardiomyopathy-derived LMS. LMS derived from amiodarone-treated patients demonstrated prolonged action potential duration, reduced excitability at higher pacing frequencies, and enhanced post pause potentiation, reflecting the drug’s established pharmacological effects.</div></div><div><h3>Conclusions</h3><div>LMS effectively capture distinct functional parameters associated with patient-specific features. These findings establish LMS as a valuable translational platform for personalized cardiac research, therapeutic testing, and precision medicine.</div></div>\",\"PeriodicalId\":100741,\"journal\":{\"name\":\"JHLT Open\",\"volume\":\"9 \",\"pages\":\"Article 100345\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JHLT Open\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950133425001405\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JHLT Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950133425001405","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
活体心肌切片(LMS)是一种新兴的转译离体模型,用于研究心肌功能、疾病机制和治疗方法。然而,离体研究结果与临床特征的关联程度尚不清楚。本研究旨在评估LMS是否保留了患者特异性的功能和病理特征,反映了不同的病因、药理方案和临床干预措施。方法取终末期心力衰竭患者(N = 12, N = 138)心肌组织切片制备300µm厚LMS。新制备LMS的功能评估包括不应期、刺激阈值、力频关系、暂停后增强、收缩力,以及钙瞬态和动作电位的同步光学记录。进行变异性和分组分析,以确定与患者特定参数相关的特征,如病因和治疗史,包括先前的左心室辅助装置(LVAD)植入和胺碘酮使用。结果与患者间变异性(来自不同患者的LMS)相比,slms表现出更低的患者内变异性(来自同一患者的LMS),证实了它们保留患者特异性功能特性的能力。lvad治疗患者的LMS表现出较低的患者内变异性和舒张张力降低,与较低的n端前b型利钠肽水平相关。病因分层揭示了不同的功能特征,包括titin突变LMS的收缩力增强,缺血性心肌病衍生LMS的收缩力与频率呈正相关。经胺碘酮治疗的LMS患者表现出动作电位持续时间延长,高起搏频率下兴奋性降低,暂停后增强,反映了药物的既定药理作用。结论slms能有效捕获与患者特异性特征相关的不同功能参数。这些发现使LMS成为个性化心脏研究、治疗试验和精准医学的一个有价值的转化平台。
Living myocardial slices retain patient-specific features: Insights into etiology and therapeutic history
Background
Living myocardial slices (LMS) are an emerging translational ex vivo model for studying myocardial function, disease mechanisms, and therapeutics. However, the extent to which ex vivo findings correlate with clinical characteristics is unknown. This study aimed to evaluate whether LMS retain patient-specific functional and pathological characteristics, reflecting diverse etiologies, pharmacological regimens, and clinical interventions.
Methods
300-µm-thick LMS were prepared from myocardial biopsies of end-stage heart failure patients (N = 12, n = 138). Functional assessment of freshly prepared LMS included refractory period, stimulation threshold, force-frequency relationship, post pause potentiation, contractile force, alongside simultaneous optical recordings of calcium transients and action potentials. Variability and grouping analyses were conducted to identify features linked to patient-specific parameters, such as etiology and therapeutic history, including prior left ventricular assist device (LVAD) implantation and amiodarone usage.
Results
LMS exhibited lower intrapatient variability (LMS from the same patient) compared to interpatient variability (LMS from different patients), confirming their ability to retain patient-specific functional properties. LMS from LVAD-treated patients exhibited reduced intrapatient variability and reduced diastolic tension, correlated with lower N-terminal pro-B-type natriuretic peptide levels. Stratification by etiology revealed distinct functional characteristics, including enhanced contractile force in titin-mutant LMS and a positive force-frequency relationship in ischemic cardiomyopathy-derived LMS. LMS derived from amiodarone-treated patients demonstrated prolonged action potential duration, reduced excitability at higher pacing frequencies, and enhanced post pause potentiation, reflecting the drug’s established pharmacological effects.
Conclusions
LMS effectively capture distinct functional parameters associated with patient-specific features. These findings establish LMS as a valuable translational platform for personalized cardiac research, therapeutic testing, and precision medicine.